Preclinical studies showed that treatment of JAK2V617F mouse models of PV with exogenous hepcidin led to normalized hematocrit levels and reduced splenomegaly with increased sequestration of iron in splenic macrophages53. This evidence concerns the gene HAMP and acquired polycythemia vera.